Trajenta 5mg Tablets (30’s) contain Linagliptin, a DPP-4 inhibitor that helps control blood sugar levels in individuals with type 2 diabetes. This medication works by increasing the levels of incretin hormones, which stimulate insulin secretion and decrease glucose production in the liver.
Trajenta is effective as a standalone therapy or in combination with other diabetes medications such as metformin, sulfonylureas, or insulin. With its once-daily dosing and minimal risk of hypoglycemia, it offers a convenient and well-tolerated option for diabetes management.
Key Benefits:
- Blood Sugar Control: Helps lower HbA1c levels and improve glycemic management.
- Weight-Neutral: Does not cause weight gain, making it suitable for individuals concerned about weight management.
- Convenient Dosing: Once-daily tablet for ease of adherence.
- Combination Therapy: Can be used alongside other antidiabetic medications for enhanced efficacy.
Dosage and Administration:
- Usual Dose: 5mg once daily, with or without food.
- Administration: Swallow the tablet whole with water. Maintain a consistent daily schedule.
Precautions:
- Type 1 Diabetes: Not suitable for patients with type 1 diabetes or diabetic ketoacidosis.
- Kidney and Liver Conditions: Inform your doctor of any existing conditions before starting Trajenta.
- Pregnancy and Breastfeeding: Use only if prescribed by your healthcare provider.
- Hypoglycemia Risk: Minimal risk when used alone but may increase if combined with sulfonylureas or insulin.
Possible Side Effects:
- Common: Nasopharyngitis, headache, cough.
- Rare: Pancreatitis, hypersensitivity reactions (e.g., rash, itching). Seek medical attention for severe symptoms.
Reviews
There are no reviews yet.